The Sprout Group - VC DATALAB profile

Website

http://www.sproutgroup.com

Sector

Financial and insurance activities

Recent investment activity

Tags

corporate venturing

KANDO id: 31676

Corporate information

Official name

The Sprout Group

Registration country

Company type

Venture capital affiliate of Credit Suisse

Relation

Credit Suisse AG

Funding rounds

Top investment portfolio themes

photonics chips (1)

microprocessors (1)

III-V chips (1)

Actual initial investment stage

N/A (3)

Investment activity status

Active investor

Selected investments

Displaying 26 - 50 of 57

Company		Profile	Country	Funding
	Paradyne Corp		United States	N/A
	Oxford Health Plans LLC		United States	N/A
	Yipes Communications Inc		United States	N/A
	Attachmate Corp		United States	N/A
	Blue Coat Systems Inc		United States	N/A
	Labcyte Inc		United States	N/A
	0-In Design Automation Inc	Provider of verification products that help verify multi-million gate ASICs and SOC designs.	United States	N/A
	Actel Corp		United States	N/A
	Netcore Systems Inc	Developer of high performance Wide Area Network (WAN) ATM switches.	United States	N/A
	Aspreva International Ltd		Canada	Series A
	Soapstone Networks Inc		United States	N/A
	netLibrary Inc		United States	N/A
	Sirna Therapeutics Inc		United States	N/A
	LeftHand Networks Inc	Offers data storage systems and IP-based storage area networks (SAN)	United States	N/A
	Infinera Corp	Telecommunications company providing next generation optical transport systems, enabled by its breakthrough digital optical networking technology.	United States	N/A
	Lathian Health Inc		United States	N/A
	Aurora Networks Inc		United States	N/A
	NxStage Medical Inc	Hemofiltration for kidney failure		N/A
	Adolor Corp		United States	N/A
	Corixa Corp		United States	N/A
	Nuvelo Inc	Optimize therapeutic outcomes for patients and their prescribing physicians.	United States	N/A
	Deltagen Bioservices Inc	Provider of drug discovery tools and services.	United States	N/A
	Metabasis Therapeutics Inc	Biopharmaceutical company focused on the discovery, development & commercialization of novel small molecule therapies drugs for diseases of the liver.	United States	N/A
	Symyx Technologies	Develops and applies high-speed combinatorial technologies to the discovery of materials for life science, chemical, and electronics applications.	United States	N/A
	AtheroGenics Inc		United States	N/A Initial investment

Current team

Past employees

Selected Products / Customers

Financials